Emmaus Life Sciences (EMMA) Operating Leases (2019 - 2026)
Emmaus Life Sciences (EMMA) reported Operating Leases of $1.3 million for Q2 2026, down 18.0% from $1.58 million a year earlier and down 1.9% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Emmaus Life Sciences posted Operating Leases of $1.41 million, up 72.9% from FY2024.
- Operating Leases has a five-year compound annual growth rate of -16.5% (FY2020 to FY2025).
- By year, Operating Leases came in at $815,000 in FY2024 (-55.7%), $1.84 million in FY2023 (-28.0%), $2.55 million in FY2022 (-21.7%) and $3.26 million in FY2021 (-6.0%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases since Q1 2025.
- Year over year, Operating Leases gained in four of the last eight quarters, with growth averaging 11.1%.
- The high point for year-over-year Operating Leases in five years was Q1 2026 (growth of 143.4%); the low point was Q1 2025 (a decline of 65.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.32 million (Q1 2026), $1.41 million (Q4 2025) and $1.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.89 Bn | 1,138.48 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 648.35 Bn | 568.21 Bn | 17.30 Bn |
| 3 | AbbVie | 504.24 Bn | 477.35 Bn | 12.70 Bn |
| 4 | Merck | 365.96 Bn | 320.33 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.28 Bn | 267.27 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn |
| 7 | Amgen | 242.76 Bn | 198.16 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.96 Bn | 169.16 Bn | 6.22 Bn |
| 9 | Pfizer | 172.99 Bn | 119.64 Bn | 10.94 Bn |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 544,000.00 |
| Dec 31, 2024 | 815,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 2.36 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Mar 31, 2022 | 3.08 Mn |
| Dec 31, 2021 | 3.26 Mn |
| Sep 30, 2021 | 3.45 Mn |
API Access
Emmaus Life Sciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();